Corvus Pharmaceuticals (CRVS) Current Leases (2019 - 2026)
Corvus Pharmaceuticals (CRVS) posted quarterly Current Leases of $428000.0 for Q1 2026, up 34.17% year-over-year from $319000.0 in Q1 2025, and up 6.2% quarter-over-quarter from $403000.0 in Q4 2025.
Corvus Pharmaceuticals (CRVS) Current Leases (2019 - 2026) Analysis & Trends
Corvus Pharmaceuticals' Current Leases history runs 8 years deep, the most recent figure standing at $428000.0 for Q1 2026.
- In Q1 2026, Current Leases rose 34.17% year-over-year to $428000.0; the TTM figure through Mar 2026 stood at $428000.0 (up 34.17% YoY), while the FY2025 annual figure was $403000.0, up 117.84% from the prior year.
- Current Leases for Q1 2026 stood at $428000.0, up from $403000.0 in the prior quarter.
- The five-year high for Current Leases was $1.4 million in Q4 2023, with the low at $185000.0 in Q4 2024.
- The 5-year median for Current Leases is $1.0 million (2024), against an average of $827588.2.
- The sharpest annual moves came in 2024 and 2025: Current Leases slumped 86.54% in 2024, then jumped 117.84% in 2025.
- Corvus Pharmaceuticals' Current Leases stood at $1.2 million in 2022, then climbed by 11.89% to $1.4 million in 2023, then plunged by 86.54% to $185000.0 in 2024, then surged by 117.84% to $403000.0 in 2025, then increased by 6.2% to $428000.0 in 2026.
- Business Quant data shows CRVS's Current Leases at $428000.0 in Q1 2026, $403000.0 in Q4 2025, and $379000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Corvus Pharmaceuticals | 1.25 Bn | 1.04 Bn | - | 454,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 454,000.00 |
| Mar 31, 2026 | 428,000.00 |
| Dec 31, 2025 | 403,000.00 |
| Sep 30, 2025 | 379,000.00 |
| Jun 30, 2025 | 355,000.00 |
| Mar 31, 2025 | 319,000.00 |
| Dec 31, 2024 | 185,000.00 |
| Sep 30, 2024 | 354,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | 1.34 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Mar 31, 2023 | 1.26 Mn |
| Dec 31, 2022 | 1.23 Mn |
| Sep 30, 2022 | 1.18 Mn |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 1.09 Mn |
| Dec 31, 2021 | 1.05 Mn |
| Sep 30, 2021 | 1.02 Mn |